ciprofloxacin has been researched along with baci-im in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (14.29) | 29.6817 |
2010's | 5 (71.43) | 24.3611 |
2020's | 1 (14.29) | 2.80 |
Authors | Studies |
---|---|
Cui, L; Hiramatsu, K; Neoh, HM; Shoji, M | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
Cieslik, W; Jampilek, J; Machura, B; Musiol, R; Nycz, JE; Polanski, J; Vejsova, M; Wolff, M | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Berscheid, A; Brötz-Oesterhelt, H; Chaidir, C; Daletos, G; Hartmann, R; Kalscheuer, R; Kassack, MU; Mokhlesi, A; Proksch, P; Rehberg, N; Stork, B; Stuhldreier, F; Sureechatchaiyan, P; Wesselborg, S; Wex, KW | 1 |
Ba, Z; Chang, L; Gou, S; Li, B; Liu, H; Ni, J; Ouyang, X; Zhang, J; Zhang, T; Zhang, Y; Zhong, C; Zhu, N; Zhu, Y | 1 |
1 review(s) available for ciprofloxacin and baci-im
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
6 other study(ies) available for ciprofloxacin and baci-im
Article | Year |
---|---|
Contribution of vraSR and graSR point mutations to vancomycin resistance in vancomycin-intermediate Staphylococcus aureus.
Topics: Amino Acid Sequence; Anti-Bacterial Agents; Bacterial Proteins; Base Sequence; Chromosome Walking; DNA-Binding Proteins; Genetic Engineering; Genome, Bacterial; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Point Mutation; Sequence Analysis, DNA; Sequence Homology, Amino Acid; Staphylococcus aureus; Vancomycin; Vancomycin Resistance | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Contribution to investigation of antimicrobial activity of styrylquinolines.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Antifungal Agents; Hydrocarbons, Halogenated; Microbial Sensitivity Tests; Molecular Structure; Quinolines; Structure-Activity Relationship | 2012 |
Cyclic Cystine-Bridged Peptides from the Marine Sponge Clathria basilana Induce Apoptosis in Tumor Cells and Depolarize the Bacterial Cytoplasmic Membrane.
Topics: Animals; Antineoplastic Agents; Drug Screening Assays, Antitumor; Enterococcus faecium; Indonesia; Marine Biology; Molecular Structure; Nuclear Magnetic Resonance, Biomolecular; Peptides, Cyclic; Porifera; Staphylococcus aureus | 2017 |
Novel Broad-Spectrum Antimicrobial Peptide Derived from Anoplin and Its Activity on Bacterial Pneumonia in Mice.
Topics: Animals; Anti-Bacterial Agents; Antimicrobial Cationic Peptides; Antineoplastic Agents; Cell Line; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Female; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Molecular Structure; Pneumonia, Bacterial; Pore Forming Cytotoxic Proteins; Structure-Activity Relationship; Wasp Venoms | 2021 |